REXAHN CORP has a total of 28 patent applications. Its first patent ever was published in 2003. It filed its patents most often in China, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are PROFECTUS BIOSCIENCES INC, GLIAMED INC and ASUBIO PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | Brazil | 4 | |
#3 | Canada | 4 | |
#4 | Republic of Korea | 4 | |
#5 | United States | 3 | |
#6 | Australia | 2 | |
#7 | Mexico | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Heterocyclic compounds | |
#5 | Measuring microorganism processes | |
#6 | Sugars | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Lee Young Bok | 17 |
#2 | Ahn Chang Ho | 12 |
#3 | Mao Lingjun | 10 |
#4 | Yoon Heejeong | 8 |
#5 | Lee Young B | 8 |
#6 | Ahn Chang H | 8 |
#7 | Lee Sang K | 7 |
#8 | Jeong Lak S | 7 |
#9 | Choi Won J | 7 |
#10 | Jiang Xiaoming | 6 |
Publication | Filing date | Title |
---|---|---|
US2005222185A1 | Nucleoside derivatives and therapeutic use thereof | |
CA2557433A1 | Quinazoline derivatives and therapeutic use thereof | |
KR20050103476A | Antisense oligonucleotides to inhibit the expression of hif-1 | |
KR20050088069A | Use of antisense oligonucleotides to inhibit the expression of akt-1 |